Anti-lipolysis-stimulated lipoprotein receptor monoclonal antibody as a novel therapeutic agent for endometrial cancer

Yoshikazu Nagase(The University of Osaka), Tadashi Kimura(Osaka University)

BMC Cancer

June 21, 2022

10.1186/s12885-022-09789-6

Cited by 7

Related Papers

Exosomal miR-99a-5p is elevated in sera of ovarian cancer patients and promotes cancer cell invasion by increasing fibronectin and vitronectin expression in neighboring peritoneal mesothelial cells

|BMC Cancer|2018|148

Suppression of <scp>LUBAC</scp>‐mediated linear ubiquitination by a specific interaction between <scp>LUBAC</scp> and the deubiquitinases <scp>CYLD</scp> and <scp>OTULIN</scp>

|Genes to Cells|2014|116

Patient-Derived Exosomes as siRNA Carriers in Ovarian Cancer Treatment

|Cancers|2024|17

Vasopressin and oxytocin receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database

|IUPHAR/BPS Guide to Pharmacology CITE|2019|8

Vasopressin and oxytocin receptors in GtoPdb v.2023.1

|IUPHAR/BPS Guide to Pharmacology CITE|2023|2